Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial. Academic Article uri icon

Overview

MeSH Major

  • Multicenter Studies as Topic
  • Myocardial Infarction
  • Peer Review, Research
  • Randomized Controlled Trials as Topic

abstract

  • Investigators misreport MI end points, but most later agree with CEC assessments. These data support standard, independent adjudication of suspected MIs for accurate reporting, which may affect evaluations of therapies, sample-size calculations, and event-rate comparisons across trials.

publication date

  • February 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11835026

Additional Document Info

start page

  • 242

end page

  • 8

volume

  • 143

number

  • 2